BPG is committed to discovery and dissemination of knowledge
Articles in Press
9/4/2026 9:43:15 AM | Browse: 6 | Download: 0
Publication Name World Journal of Diabetes
Manuscript ID 123730
DOI 10.4239/wjd.123730
Country China
Category Anesthesiology
Manuscript Type Basic Study
Article Title Preventive carnosine supplementation attenuates painful diabetic neuropathy via restoring mitochondrial function and suppressing inflammasome activation
Manuscript Source Unsolicited Manuscript
All Author List Zhuo-Ying Yu, Jing Yang, Ye Jiang, Yong-Zheng Han, Min Wei, Jia-Yin Shou, Shi-Xiong Shen, Yan-Han Lyu, Xin-Sheng Li, Qian Chen, Xin-Ru Zhao, Guo-Gang Xing, Da-Qing Ma and Min Li
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China No. 82001329 and 82071411
Beijing Municipal Natural Science Foundation No. 7204325
Key Research Foundation of Peking University Third Hospital No. BYSYZD2019036
Special Fund of the National Clinical Key Specialty Construction Program, China (2025)
Corresponding Author Min Li, Chief Physician, Deputy Director, MD, Professor, Department of Anesthesiology, Peking University Third Hospital, No. 49 North Garden Road, Haidian District, Beijing 100191, China. liminanesth@bjmu.edu.cn
Key Words Painful diabetic neuropathy; Mitochondrial fission; Dynamin-related protein 1; NOD-like receptor pyrin domain-containing protein 3 inflammasome; Carnosine
Core Tip Painful diabetic neuropathy (PDN) is characterized by impaired mitochondrial function and reduced carnosine levels in the dorsal root ganglia. Untargeted metabolomic analysis identified carnosine deficiency as a metabolic alteration associated with PDN. Preventive carnosine supplementation alleviated behavioral, electrophysiological, and mitochondrial abnormalities in diabetic rats and was associated with reduced dynamin-related protein 1-related mitochondrial fission and NOD-like receptor pyrin domain-containing protein 3 inflammasome activation in dorsal root ganglia. These findings were further supported by complementary in vitro experiments, collectively supporting further preclinical and translational evaluation of carnosine as a potential early-intervention strategy for PDN.
Citation Yu ZY, Yang J, Jiang Y, Han YZ, Wei M, Shou JY, Shen SX, Lyu YH, Li XS, Chen Q, Zhao XR, Xing GG, Ma DQ, Li M. Preventive carnosine supplementation attenuates painful diabetic neuropathy via restoring mitochondrial function and suppressing inflammasome activation. World J Diabetes 2026; In press
PDF 123730-in-press.pdf
Received
2026-06-02 07:34
Peer-Review Started
2026-06-05 05:49
First Decision by Editorial Office Director
Return for Revision
2026-06-25 07:09
Revised
2026-07-08 06:46
Publication Fee Transferred
2026-07-20 11:52
Second Decision by Editor
2026-08-18 09:56
Second Decision by Editor-in-Chief
2026-08-20 10:45
Final Decision by Editorial Office Director
2026-09-04 09:43
Articles in Press
2026-09-04 09:43
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-9358 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com